When the Department of Justice investigated a proposed joint venture between SABMiller and Molson Coors Brewing Company, Professor Salop and CRA assisted Miller’s antitrust counsel. We analyzed pricing, demand, competitive effects, and efficiencies. The investigation was closed, and the joint venture proceeded.

When a pharmaceutical product franchise was faced with regulatory pricing pressure, new competitors, and the entry of biosimilars, they came to CRA. We analyzed their options, developed a country segmentation strategy, and recommended an optimal reaction to biosimilar entry scenarios.

Charles River Associates recently assisted a company that was losing $35 million annually. Our advice positioned them to earn $35 million annually—at which time their parent company chose to divest them, realizing a transaction price of $400 million.

Charles River Associates helped Sprint obtain a favorable outcome at trial when Vonage infringed on several of their patents related to voice-over-Internet protocol technology. Subsequent to that trial, we assisted Sprint in connection with negotiations that resulted in an $80 million settlement.

CRA provided accounting analysis and expert testimony in two cases decided by the US Supreme Court regarding mutual fund fees, ultimately contributing to our client’s successful defense.